These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 22244977

  • 1. A broad-spectrum matrix metalloproteinase inhibitor prevents hemorrhagic complications induced by tissue plasminogen activator in mice.
    Mishiro K, Ishiguro M, Suzuki Y, Tsuruma K, Shimazawa M, Hara H.
    Neuroscience; 2012 Mar 15; 205():39-48. PubMed ID: 22244977
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A Rho kinase (ROCK) inhibitor, fasudil, prevents matrix metalloproteinase-9-related hemorrhagic transformation in mice treated with tissue plasminogen activator.
    Ishiguro M, Kawasaki K, Suzuki Y, Ishizuka F, Mishiro K, Egashira Y, Ikegaki I, Tsuruma K, Shimazawa M, Yoshimura S, Iwama T, Hara H.
    Neuroscience; 2012 Sep 18; 220():302-12. PubMed ID: 22710066
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia.
    Li Q, Han X, Lan X, Hong X, Li Q, Gao Y, Luo T, Yang Q, Koehler RC, Zhai Y, Zhou J, Wang J.
    Neurobiol Dis; 2017 Dec 18; 108():173-182. PubMed ID: 28830843
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. IMM-H004 prevents toxicity induced by delayed treatment of tPA in a rat model of focal cerebral ischemia involving PKA-and PI3K-dependent Akt activation.
    Zuo W, Chen J, Zhang S, Tang J, Liu H, Zhang D, Chen N.
    Eur J Neurosci; 2014 Jun 18; 39(12):2107-18. PubMed ID: 24649933
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Tissue plasminogen activator prevents restoration of tight junction proteins through upregulation of angiopoietin-2.
    Mishiro K, Ishiguro M, Suzuki Y, Tsuruma K, Shimazawa M, Hara H.
    Curr Neurovasc Res; 2013 Feb 18; 10(1):39-48. PubMed ID: 23151074
    [Abstract] [Full Text] [Related]

  • 14. High-density lipoprotein-based therapy reduces the hemorrhagic complications associated with tissue plasminogen activator treatment in experimental stroke.
    Lapergue B, Dang BQ, Desilles JP, Ortiz-Munoz G, Delbosc S, Loyau S, Louedec L, Couraud PO, Mazighi M, Michel JB, Meilhac O, Amarenco P.
    Stroke; 2013 Mar 18; 44(3):699-707. PubMed ID: 23422087
    [Abstract] [Full Text] [Related]

  • 15. NAD replenishment with nicotinamide mononucleotide protects blood-brain barrier integrity and attenuates delayed tissue plasminogen activator-induced haemorrhagic transformation after cerebral ischaemia.
    Wei CC, Kong YY, Hua X, Li GQ, Zheng SL, Cheng MH, Wang P, Miao CY.
    Br J Pharmacol; 2017 Nov 18; 174(21):3823-3836. PubMed ID: 28812311
    [Abstract] [Full Text] [Related]

  • 16. Ascorbic Acid Reduces the Adverse Effects of Delayed Administration of Tissue Plasminogen Activator in a Rat Stroke Model.
    Allahtavakoli M, Amin F, Esmaeeli-Nadimi A, Shamsizadeh A, Kazemi-Arababadi M, Kennedy D.
    Basic Clin Pharmacol Toxicol; 2015 Nov 18; 117(5):335-9. PubMed ID: 25899606
    [Abstract] [Full Text] [Related]

  • 17. Hydrogen Sulfide Attenuates Tissue Plasminogen Activator-Induced Cerebral Hemorrhage Following Experimental Stroke.
    Liu H, Wang Y, Xiao Y, Hua Z, Cheng J, Jia J.
    Transl Stroke Res; 2016 Jun 18; 7(3):209-19. PubMed ID: 27018013
    [Abstract] [Full Text] [Related]

  • 18. Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats.
    Sumii T, Lo EH.
    Stroke; 2002 Mar 18; 33(3):831-6. PubMed ID: 11872911
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.